Wych Elm Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 59.93%
(FY 2023)
- Profit 23.81%
(FY 2023)
- Ebitda 71.61%
(FY 2023)
- Net Worth 792.38%
(FY 2023)
- Total Assets 23.63%
(FY 2023)
About Wych Elm Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Swarnali Chakraborty, Jayant Bhattacharjee, and Sukant Bhattacharjee serve as directors at the Company.
- CIN/LLPIN
U33110WB2011PLC166728
- Company No.
166728
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2011
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Wych Elm Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swarnali Chakraborty  | Whole-Time Director | 16-Nov-2011 | Current |
| Jayant Bhattacharjee | Director | 08-Aug-2022 | Current |
| Sukant Bhattacharjee | Director | 11-Sep-2019 | Current |
Financial Performance of Wych Elm Laboratories.
Wych Elm Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.93% increase. The company also saw a substantial improvement in profitability, with a 23.81% increase in profit. The company's net worth Soared by an impressive increase of 792.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wych Elm Laboratories?
In 2023, Wych Elm Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_437898.webp)
Informatik Security Solutions Private LimitedActive 9 years 8 monthsJayant Bhattacharjee is a mutual person
Daggett Info Healthcare Solutions Private LimitedActive 1 year 6 monthsSukant Bhattacharjee is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wych Elm Laboratories?
Wych Elm Laboratories has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wych Elm Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wych Elm Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
